The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice
Open accessAbstract
Mutations in leucine-rich repeat kinase 2 (LRRK2) cause late-onset Parkinson's disease (PD), but the underlying pathophysiological mechanisms and the normal function of this large multidomain protein remain speculative. To address the role of this protein in vivo, we generated three different LRRK2 mutant mouse lines. Mice completely lacking the LRRK2 protein (knock-out, KO) showed an early-onset (age 6 weeks) marked increase in number and size of secondary lysosomes in kidney proximal tubule cells and lamellar bodies in lung type II cells. Mice expressing a LRRK2 kinase-dead (KD) mutant from the endogenous locus displayed similar early-onset pathophysiological changes in kidney but not lung. KD mutants had dramatically reduced full-length LRRK2 protein levels in the kidney and this genetic effect was mimicked pharmacologically in wild-type mice treated with a LRRK2-selective kinase inhibitor. Knock-in (KI) mice expressing the G2019S PD-associated mutation that increases LRRK2 kinase activity showed none of the LRRK2 protein level and histopathological changes observed in KD and KO mice. The autophagy marker LC3 remained unchanged but kidney mTOR and TCS2 protein levels decreased in KD and increased in KO and KI mice. Unexpectedly, KO and KI mice suffered from diastolic hypertension opposed to normal blood pressure in KD mice. Our findings demonstrate a role for LRRK2 in kidney and lung physiology and further show that LRRK2 kinase function affects LRRK2 protein steady-state levels thereby altering putative scaffold/GTPase activity. These novel aspects of peripheral LRRK2 biology critically impact ongoing attempts to develop LRRK2 selective kinase inhibitors as therapeutics for PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,005
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
the NIDDK IBD Genetics Consortium, Barrett, J. C., the Belgian-French IBD Consortium, the Wellcome Trust Case Control Consortium, Hansoul, S., Nicolae, D. L., Cho, J. H., Duerr, R. H., Rioux, J. D., Brant, S. R., et al. (2008) · Nature Genetics · doi:10.1038/ng.175 · Cited by 2,593
Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease
Paisán-Ruı́z, C., Jain, S., Evans, E. W., Gilks, W. P., Simón, J., van der Brug, M., de Munain, A. L., Aparicio, S., Gil, A. M., Khan, N., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.10.023 · Cited by 2,405
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Simón-Sánchez, J., Schulte, C., Bras, J. M., Sharma, M., Gibbs, J. R., Berg, D., Paisan-Ruiz, C., Lichtner, P., Scholz, S. W., Hernandez, D. G., et al. (2009) · Nature Genetics · doi:10.1038/ng.487 · Cited by 1,751
Molecular Mechanisms of Human Hypertension
Lifton, R. P., Gharavi, A. G., & Geller, D. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00241-0 · Cited by 1,686
Human Hypertension Caused by Mutations in WNK Kinases
Wilson, F. H., Disse-Nicodème, S., Choate, K. A., Ishikawa, K., Nelson-Williams, C., Desitter, I., Gunel, M., Milford, D. V., Lipkin, G. W., Achard, J.-M., et al. (2001) · Science · doi:10.1126/science.1062844 · Cited by 1,487
Healy, D. G., Falchi, M., O'Sullivan, S. S., Bonifati, V., Durr, A., Bressman, S., Brice, A., Aasly, J., Zabetian, C. P., Goldwurm, S., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70117-0 · Cited by 1,425
Satake, W., Nakabayashi, Y., Mizuta, I., Hirota, Y., Ito, C., Kubo, M., Kawaguchi, T., Tsunoda, T., Watanabe, M., Takeda, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.485 · Cited by 1,324
Schwenk, F., Baron, U., & Rajewsky, K. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.24.5080 · Cited by 1,289
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
West, A. B., Moore, D. J., Biskup, S., Bugayenko, A., Smith, W. W., Ross, C. A., Dawson, V. L., & Dawson, T. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507360102 · Cited by 1,228 · cited 1×
“Nonetheless, the G2019S mutation is located in the kinase domain and increases LRRK2 kinase activity (12,13) and toxicity (14–17).”
Autophagy gone awry in neurodegenerative diseases
Wong, E., & Cuervo, A. M. (2010) · Nature Neuroscience · doi:10.1038/nn.2575 · Cited by 815
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson’s disease
Neumann, J., Bras, J., Deas, E., O'Sullivan, S. S., Parkkinen, L., Lachmann, R. H., Li, A., Holton, J., Guerreiro, R., Paudel, R., et al. (2009) · Brain · doi:10.1093/brain/awp044 · Cited by 696
Kinase activity of mutant LRRK2 mediates neuronal toxicity
Smith, W. W., Pei, Z., Jiang, H., Dawson, V. L., Dawson, T. M., & Ross, C. A. (2006) · Nature Neuroscience · doi:10.1038/nn1776 · Cited by 619
The Familial Parkinsonism Gene LRRK2 Regulates Neurite Process Morphology
MacLeod, D., Dowman, J., Hammond, R., Leete, T., Inoue, K., & Abeliovich, A. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.008 · Cited by 564
The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
Cookson, M. R. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2935 · Cited by 539
Localization of LRRK2 to membranous and vesicular structures in mammalian brain
Biskup, S., Moore, D. J., Celsi, F., Higashi, S., West, A. B., Andrabi, S. A., Kurkinen, K., Yu, S., Savitt, J. M., Waldvogel, H. J., et al. (2006) · Annals of Neurology · doi:10.1002/ana.21019 · Cited by 511
Tong, Y., Yamaguchi, H., Giaime, E., Boyle, S., Kopan, R., Kelleher, R. J., & Shen, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004676107 · Cited by 501
Role of autophagy in G2019S‐LRRK2‐associated neurite shortening in differentiated SH‐SY5Y cells
Plowey, E. D., Cherra, S. J., Liu, Y., & Chu, C. T. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05217.x · Cited by 493
Jaleel, M., Nichols, R. J., Deak, M., Campbell, D. G., Gillardon, F., Knebel, A., & Alessi, D. R. (2007) · Biochemical Journal · doi:10.1042/bj20070209 · Cited by 472
Wheater's Functional Histology: A Text and Colour Atlas
Young, B., O'Dowd, G., & Woodford, P. (1993) · Cited by 436
Alegre-Abarrategui, J., Christian, H., Lufino, M. M. P., Mutihac, R., Venda, L. L., Ansorge, O., & Wade-Martins, R. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp346 · Cited by 432
Phosphorylation of 4E‐BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila
Imai, Y., Gehrke, S., Wang, H., Takahashi, R., Hasegawa, K., Oota, E., & Lu, B. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.163 · Cited by 430
Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
Deng, X., Dzamko, N., Prescott, A., Davies, P., Liu, Q., Yang, Q., Lee, J.-D., Patricelli, M. P., Nomanbhoy, T. K., Alessi, D. R., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.538 · Cited by 417
Lipofuscin: Formation, Distribution, and Metabolic Consequences
JUNG, T., BADER, N., & GRUNE, T. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1404.008 · Cited by 415
Disorders of Lysosome-Related Organelle Biogenesis: Clinical and Molecular Genetics
Huizing, M., Helip-Wooley, A., Westbroek, W., Gunay-Aygun, M., & Gahl, W. A. (2008) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.9.081307.164303 · Cited by 415
Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression
Gehrke, S., Imai, Y., Sokol, N., & Lu, B. (2010) · Nature · doi:10.1038/nature09191 · Cited by 398
The RIP kinases: crucial integrators of cellular stress
Meylan, E., & Tschopp, J. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.01.003 · Cited by 382
Dzamko, N., Deak, M., Hentati, F., Reith, A. D., Prescott, A. R., Alessi, D. R., & Nichols, R. J. (2010) · Biochemical Journal · doi:10.1042/bj20100784 · Cited by 372
Wheater's Functional Histology: A Text and Colour Atlas
Kovacs, E. J. (2001) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2001-125-708b-wfhata · Cited by 349
Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
Lee, B. D., Shin, J.-H., VanKampen, J., Petrucelli, L., West, A. B., Ko, H. S., Lee, Y.-I., Maguire-Zeiss, K. A., Bowers, W. J., Federoff, H. J., et al. (2010) · Nature Medicine · doi:10.1038/nm.2199 · Cited by 329
LRRK2 regulates synaptic vesicle endocytosis
Shin, N., Jeong, H., Kwon, J., Heo, H. Y., Kwon, J. J., Yun, H. J., Kim, C.-H., Han, B. S., Tong, Y., Shen, J., et al. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.02.015 · Cited by 329
An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family
Funayama, M., Hasegawa, K., Ohta, E., Kawashima, N., Komiyama, M., Kowa, H., Tsuji, S., & Obata, F. (2005) · Annals of Neurology · doi:10.1002/ana.20484 · Cited by 264
Receptor-mediated endocytosis in renal proximal tubule
Christensen, E. I., Verroust, P. J., & Nielsen, R. (2009) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0685-8 · Cited by 231
Weaver, T. E., Na, C.-L., & Stahlman, M. (2002) · Seminars in Cell & Developmental Biology · doi:10.1016/s1084952102000551 · Cited by 225
GTPase Activity Plays a Key Role in the Pathobiology of LRRK2
Xiong, Y., Coombes, C. E., Kilaru, A., Li, X., Gitler, A. D., Bowers, W. J., Dawson, V. L., Dawson, T. M., & Moore, D. J. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000902 · Cited by 196
Apoptotic mechanisms in mutant LRRK2-mediated cell death
Iaccarino, C., Crosio, C., Vitale, C., Sanna, G., Carrì, M. T., & Barone, P. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm080 · Cited by 190
Mutations in the Na-Cl Cotransporter Reduce Blood Pressure in Humans
Cruz, D. N., Simon, D. B., Nelson-Williams, C., Farhi, A., Finberg, K., Burleson, L., Gill, J. R., & Lifton, R. P. (2001) · Hypertension · doi:10.1161/01.hyp.37.6.1458 · Cited by 175
Neuron atrophy during aging: programmed or sporadic?
Finch, C. E. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90134-8 · Cited by 166
Li, X., Wang, Q. J., Pan, N., Lee, S., Zhao, Y., Chait, B. T., & Yue, Z. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017153 · Cited by 164
Dusonchet, J., Kochubey, O., Stafa, K., Young, S., Zufferey, R., Moore, D. J., Schneider, B. L., & Aebischer, P. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.5092-10.2011 · Cited by 160
Role of Mammalian Target of Rapamycin Signaling in Compensatory Renal Hypertrophy
Chen, J., Chen, J., Neilson, E. G., & Harris, R. C. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004100894 · Cited by 137
Lipofuscin Pigment Accumulation and Distribution in Five Rat Organs as a Function of Age
Reichel, W. (1968) · Journal of Gerontology · doi:10.1093/geronj/23.2.145 · Cited by 132
Vitari, A. C., Deák, M., Collins, B., MORRICE, N. A., Prescott, A. R., PHELAN, A., Humphreys, S., & Alessi, D. R. (2004) · Biochemical Journal · doi:10.1042/bj20031692 · Cited by 129
Investigation of leucine‐rich repeat kinase 2: Enzymological properties and novel assays
Anand, V. S., Reichling, L. J., Lipinski, K., Stochaj, W. R., Duan, W., Kelleher, K. S., Pungaliya, P., Brown, E. L., Reinhart, P. H., Somberg, R. L., et al. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06789.x · Cited by 127
Kumar, A., Greggio, E., Beilina, A. G., Kaganovich, A., Chan, D., Taymans, J., Wolozin, B. L., & Cookson, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008730 · Cited by 103
Looyenga, B. D., Furge, K. A., Dykema, K. J., Koeman, J. M., Swiatek, P. J., Giordano, T. J., West, A. B., Resau, J. H., Teh, B. T., & MacKeigan, J. P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012500108 · Cited by 99
A transgenic mouse strain expressing four drug-selectable marker genes
Tucker, K. L., Wang, Y., Dausman, J. A., & Jaenisch, R. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.18.3745 · Cited by 95
Higashi, S., Moore, D. J., Yamamoto, R., Minegishi, M., Sato, K., Togo, T., Katsuse, O., Uchikado, H., Furukawa, Y., Hino, H., et al. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181b44ed8 · Cited by 85
Ochs, M. (2009) · Cellular Physiology and Biochemistry · doi:10.1159/000272061 · Cited by 80
Regulation of mRNA translation in renal physiology and disease
Kasinath, B. S., Féliers, D., Sataranatarajan, K., Choudhury, G. G., Lee, M. J., & Mariappan, M. M. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90748.2008 · Cited by 69
LRRK2 in Parkinson’s disease: biochemical functions
Anand, V. S., & Braithwaite, S. P. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07341.x · Cited by 67
Death in the substantia nigra: a motor tragedy
Esposito, E., Matteo, V. D., & Giovanni, G. D. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.6.677 · Cited by 63
Pathophysiological Role of Autophagy: Lesson from Autophagy-Deficient Mouse Models
Ichimura, Y., & Komatsu, M. (2011) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.60.329 · Cited by 54
Involvement of type II pneumocytes in the pathogenesis of chronic obstructive pulmonary disease
Zhao, C.-Z., Fang, X., Wang, D., Fa-di, T., & Wang, X. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.06.018 · Cited by 52
(1976) · Food and Cosmetics Toxicology · doi:10.1016/s0015-6264(76)80037-5 · Cited by 48
mTORβ Splicing Isoform Promotes Cell Proliferation and Tumorigenesis
Panasyuk, G., Nemazanyy, I., Zhyvoloup, A., Filonenko, V. V., Davies, D. C., Robson, M. P., Pedley, R. B., Waterfield, M. D., & Gout, I. T. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.056085 · Cited by 48
Neurocirculatory and nigrostriatal abnormalities in Parkinson disease from LRRK2 mutation
Goldstein, D. S., Imrich, R., Peckham, E. L., Holmes, C. S., Lopez, G. J., Crews, C., Hardy, J., Singleton, A., & Hallett, M. (2007) · Neurology · doi:10.1212/01.wnl.0000268696.57912.64 · Cited by 33
Expression of leucine‐rich‐repeat‐kinase 2 (LRRK2) during embryonic development
Zechel, S., Meinhardt, A., Unsicker, K., & Halbach, O. V. B. U. (2010) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2010.04.002 · Cited by 32
Pathways of proteolysis affecting renal cell growth
Franch, H. A. (2002) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200207000-00012 · Cited by 32
Ohta, E., Katayama, Y., Kawakami, F., Yamamoto, M., Tajima, K., Maekawa, T., Iida, N., Hattori, S., & Obata, F. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.10.034 · Cited by 27
Glucocerebrosidase mutations are not a common risk factor for Parkinson disease in North Africa
Nishioka, K., Vilariño‐Güell, C., Cobb, S. A., Kachergus, J. M., Ross, O. A., Wider, C. W., Gibson, R. A., Hentati, F., & Farrer, M. J. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.11.066 · Cited by 27
Cited by
RETRACTED ARTICLE: Parkin and PINK1 mitigate STING-induced inflammation
Sliter, D. A., Martinez, J., Hao, L., Chen, X., Sun, N., Fischer, T. D., Burman, J. L., Li, Y., Zhang, Z., Narendra, D. P., et al. (2018) · Nature · doi:10.1038/s41586-018-0448-9 · Cited by 1,287
RetractedPhosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases
Steger, M., Tonelli, F., Ito, G., Davies, P., Trost, M., Vetter, M., Wachter, S., Lorentzen, E., Duddy, G., Wilson, S., et al. (2016) · eLife · doi:10.7554/elife.12813 · Cited by 1,042
Parkinson’s disease: animal models and dopaminergic cell vulnerability
Blesa, J., & Przedborski, S. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00155 · Cited by 480
Defects in trafficking bridge Parkinson’s disease pathology and genetics
Abeliovich, A., & Gitler, A. D. (2016) · Nature · doi:10.1038/nature20414 · Cited by 462
Deyaert, E., Wauters, L., Guaitoli, G., Konijnenberg, A., Leemans, M., Terheyden, S., Petrovic, A., Gallardo, R., Nederveen-Schippers, L. M., Athanasopoulos, P. S., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01103-4 · Cited by 457
Metadata
- Authors
- Herzig, M. C., Kolly, C., Persohn, E., Theil, D., Schweizer, T., Hafner, T., Stemmelen, C., Troxler, T. J., Schmid, P., Danner, S., Schnell, C. R., Mueller, M., Kinzel, B., Grevot, A., Bolognani, F., Stirn, M., Kuhn, R. R., Kaupmann, K., van der Putten, P. H., Rovelli, G., & Shimshek, D. R.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-08-09
- Volume
- 20
- Issue
- 21
- Pages
- 4209-4223
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2103454698
- Cited by
- 360
- References
- 62
- FWCI
- 12.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.